Episode 8: Protecting the Synapse from Amyloid Toxicity in Alzheimer’s Disease

Featuring:
Anthony Caggiano, M.D., Ph.D. (moderator)
Cognition Therapeutics		 Chief Medical Officer
Mary Hamby, Ph.D. (moderator)
Cognition Therapeutics		 Vice President of Research
Everard (Jort) Vijverberg, MD, PhD
Alzheimer Center at Amsterdam University Medical Center		 Neurologist and CNS Trial Specialist
Tara Spires Jones, DPhil
University of Edinburgh		 Personal Chair of Neurodegeneration and Deputy Director of the Centre for Discovery Brain Sciences
Index:
0:00 Introduction
3:49 Findings from SEQUEL
6:45 Clinical observations of CT1812 engagement
9:08 Proteomic evidence of CT1812 engagement
11:52 CT1812’s ongoing Phase 2 study

share this video

Scroll to Top

Thank you for your interest in Cognition’s publications. A PDF of the poster you are interested in will be made available in accordance with the congress’ embargo policy. Please check back soon. 

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

Continue to www.brightfocus.org

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

Continue to www.preventblindness.org

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

Continue to https://lewybodyresourcecenter.org/

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

Continue to www.lbda.org

You are now leaving the Cognition Therapeutics website

Cognition Therapeutics assumes no responsibility for the content of third-party website. Neither does Cognition control, endorse or guarantee any aspect of your use of third-party sites. We encourage you to read and evaluate terms of use, privacy and other policies of the destination site as they may differ from Cognition’s policies.

Continue to www.alz.org